AGM/EGMJul 31, 2026, 04:08 PM
Evogene to Hold AGM on Sep 4; Board Election, Reverse Split on Agenda
AI Summary
Evogene Ltd. announced its Annual General Meeting of Shareholders to be held on September 4, 2026, where shareholders will vote on several key proposals. These include the re-election of directors, with a contested election between the Board-nominated Evogene Slate and a shareholder-nominated Pure Capital Slate, an increase in authorized share capital, and a framework for a reverse share split. The Board also highlighted significant operational transformations, including a reduction in headcount, decreased cash burn, and strategic portfolio optimization, while urging shareholders to support its proposed director slate.
Key Highlights
- Annual General Meeting scheduled for September 4, 2026, to vote on key proposals.
- Shareholders to vote on two slates for Board of Directors: Evogene Slate vs. Pure Capital Slate.
- Proposal to increase authorized share capital by 120,000,000 ordinary shares.
- Framework for a reverse share split at a ratio between 1-for-2 and 1-for-15.
- Re-appointment of Kost Forer Gabbay & Kasierer as independent auditors.
- Company reduced headcount from 117 to 39 employees, streamlining operations.
- Group cash burn decreased from $20.5M in 2024 to expected $8.5-$9.5M in 2026.
- Raised approximately $14.2M in new capital and sold Lavie Bio for $15.25M.
Price Impact
More from EVGN
More in AGM/EGM